covid-19-india Archives | Future Medicine India


Nanoparticle-based RNA extraction kit for detection of COVID-19 is set to be commercially launched

Agappe Chitra Magna, a magnetic nanoparticle-based RNA extraction kit used in the detection of COVID-19 will be commercially launched on May 21, 2020, announced the Ministry of Health and Family Welfare.

FM News Network
Read More..

Centre extends lockdown till May 31; Number of new COVID-19 cases spike to a new high

India enters lockdown 4.0 from May 18 as the National Disaster Management Authority (NDMA) on Sunday issued an order extending the quarantine till May 31.

FM News Network

COVID-19 impact: Private hospitals to report 50% drop in April, May revenues

Investment information and credit rating agency ICRA Limited expects the revenues of the entities in healthcare sector to fall by 50% in the months of April and May following the spread of the Covid-19 pandemic.


Glenmark begins Phase-3 trials on antiviral favipiravir for COVID-19 patients

Glenmark Pharmaceuticals, a research focused drugmaker, has started Phase-3 clinical trials of antiviral molecule favipiravir to treat coronavirus patients in India.

FM News Network

Azim Premji, Wipro becomes largest corporate supporter in India’s fight against COVID-19

As India’s COVID crisis is worsening with more number of positive cases and limited healthcare capacities, help from corporate houses and private enterprises has become critical. Among the helping hands, billionaire Azim Premji and his companies have proved to be the biggest supporter towards this cause so far in the country.

FM News Network

Fighting COVID-19: The Kerala Experience

Kerala, the second most densely populated state in India with a current population of 33,406,061, often finds itself in the headlines these days due to its success in containing the dreaded COVID-19.

Dr Padmanabha Shenoy

SCTIMST to develop convalescent plasma therapy protocol for COVID-19

Indian Council for Medical Research (ICMR) has approved Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Kerala, to develop a protocol for convalescent plasma therapy trial to treat severely ill COVID-19 patients.

Divya Choyikutty